Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species.
about
Signaling and stress: The redox landscape in NOS2 biologyDNA-damaging autoantibodies and cancer: the lupus butterfly theory.Reactions of HNO with heme proteins: new routes to HNO-heme complexes and insight into physiological effects.Glutathione sulfinamide serves as a selective, endogenous biomarker for nitroxyl after exposure to therapeutic levels of donors.The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.Chemistry meets biology in colitis-associated carcinogenesisOrthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm.Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer.The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations.Biological signaling by small inorganic moleculesThe pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NOSynthesis and characterization of lithium oxonitrate (LiNO).Targeting nitric oxide for cancer therapy.S-Nitrosation Mediates Multiple Pathways That Lead to Tumor Progression in Estrogen Receptor-Negative Breast Cancer.Microglia induce neurotoxicity via intraneuronal Zn(2+) release and a K(+) current surge.The reemergence of nitric oxide and cancerThe chemical biology of nitric oxide: implications in cellular signalingAs(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes.Arsenite-induced ROS/RNS generation causes zinc loss and inhibits the activity of poly(ADP-ribose) polymerase-1.Gamma Radiation-Induced Damage in the Zinc Finger of the Transcription Factor IIIAJS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C).The emergence of nitroxyl (HNO) as a pharmacological agent.Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected].Computational investigations of HNO in biology.HNO binding in a heme protein: structures, spectroscopic properties, and stabilities.HNO/NO Conversion Mechanisms of Cu-Based HNO Probes with Implications for Cu,Zn-SOD.Alpha-synuclein induced cell death in mouse hippocampal (HT22) cells is mediated by nitric oxide-dependent activation of caspase-3.Nitric oxide inactivation mechanisms in the brain: role in bioenergetics and neurodegeneration.Lipoxygenases and poly(ADP-ribose) polymerase in amyloid beta cytotoxicityNMR, IR/Raman, and structural properties in HNO and RNO (R = alkyl and aryl) metalloporphyrins with implication for the HNO-myoglobin complex.Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control.A bioorthogonal 'turn-on' fluorescent probe for tracking mitochondrial nitroxyl formation.
P2860
Q28833738-6B970530-9E5E-40DF-B658-21A3C6A86D43Q30251723-F28C34A3-5D7D-4068-A2C5-62454BB4934DQ34030551-7827924A-C96E-49FB-97D2-036171DE87F9Q34622608-38A3D005-0A2D-4213-8614-B2CB38480BE7Q34756677-73F66502-8E29-4371-8ADB-EFD40DF62B84Q35047726-5F29E2CB-BDF5-49D1-A82A-FE0EFCE24916Q35175535-0D78F7BC-EDFD-426B-8CFE-B4383CD0AC35Q35638851-B28862D9-E64E-4D53-82D3-E55982A0B787Q35672323-F60B0E58-2307-471C-93B4-8299B1EA07F8Q36376440-03400EFD-BBCD-4BEA-B1A2-D2E9DDBD6432Q36408421-501E684C-1170-4435-86A0-8F715CE6373EQ36457239-F6DF9CA4-3259-490B-8F01-4CCC4DC09211Q36709690-E49C966F-D07B-4423-A2BE-A0DE4B829B67Q36720882-DBD11D01-F0AA-499C-B5FA-9C2BE479DEF3Q36922363-BEC48A95-F337-43EE-97C3-632A14DA7B09Q36932882-423B1C68-268E-48D0-8E5A-1E48E5C8E52DQ36948369-0CFACDE0-EB65-44C6-BFF6-8BFAEF05CCF3Q36973143-C77A8025-6993-4E43-9B01-58EE5C6A3349Q37154325-48E1133B-3684-4E38-8F54-DE15F45B79ECQ37359820-FA140DB2-48F4-4A81-94D1-11A44A3B6B8EQ37372590-0177075E-55AC-41EF-80F2-6089F07624D7Q37385327-1AF59A2E-5383-4A98-8608-82D18E0FC19FQ37388923-6D8DE765-F9D1-47C3-95C3-76DF133355D1Q38055957-7971644F-9360-4AE4-895C-F2F583CCB9F4Q38273201-51310FB2-953D-4BC3-9B18-219448792170Q38733258-BA1D3A96-F2A4-456F-8C57-F1BE65BDFBA0Q39679022-740379CE-19AE-4D86-A3C0-872594CB9F34Q41832099-D6674C8B-8DCD-44B1-BA16-1B170042FACBQ42711059-13A630D9-415B-441E-9518-9354B17A703BQ42918717-C432997E-26CA-487B-A220-9104AAB7E9F2Q45103332-47157102-70D5-49C4-9D8E-417B5180AD64Q48577696-F55D5DB8-1E32-4813-A3A2-2C59E1F3873F
P2860
Inhibition of poly(ADP-RIBOSE) polymerase (PARP) by nitric oxide and reactive nitrogen oxide species.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Inhibition of poly(ADP-RIBOSE) ...... active nitrogen oxide species.
@en
type
label
Inhibition of poly(ADP-RIBOSE) ...... active nitrogen oxide species.
@en
prefLabel
Inhibition of poly(ADP-RIBOSE) ...... active nitrogen oxide species.
@en
P2093
P1476
Inhibition of poly(ADP-RIBOSE) ...... active nitrogen oxide species.
@en
P2093
David A Wink
Jacques Laval
Katrina M Miranda
Michael Graham Espey
Olga Sidorkina
P304
P356
10.1016/J.FREERADBIOMED.2003.08.015
P577
2003-12-01T00:00:00Z